top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hIFNGR1/hIFNG/hIFNGR2 mice
Strain Name

C57BL/6-Ifngr1tm1(IFNGR1)BcgenIfngtm1(IFNG)BcgenIfngr2tm1(IFNGR2)Bcgen/Bcgen

Common Name  B-hIFNGR1/hIFNG/hIFNGR2 mice
Background C57BL/6 Catalog number 130949
Related Genes 
IFNG: IFG, IFI, IMD69,IFN-γ IFNGR1: CD119, IFNGR, IMD27A, IMD27B;

IFNGR2 also named AF-1; 

IFGR2; IMD28; IFNGT1

mRNA expression analysis


from clipboard


IFNG and IFNGR1 expression analysis in B-hIFNGR1/hIFNG mice by RT-PCR. Human IFNG and IFNGR1 mRNA were detectable in splenocytes of the homozygous B-hIFNGR1/hIFNG mice (H/H) but not in wild-type mice (+/+).

Protein expression analysis


from clipboard

from clipboard


IFNG and IFNGR1 expression analysis in B-hIFNGR1/IFNG mice. (A) IFNG expression. Serum was collected from wild-type C57BL/6 mice and homozygous B-hIFNGR1/hIFNG mice (anti-CD3ε antibody, 2 hours, in vivo) and analyzed by ELISA with species-specific IFNG ELISA kit. Human IFNG was exclusively detectable in homozygous B-hIFNGR1/hIFNG mice but not in wild-type mice. (B) IFNGR1 expression. Peritoneal derived macrophage cells were collected, and analyzed by flow cytometry with anti-IFNGR1 antibody. Human IFNGR1 was detectable in B-hIFNGR1/hIFNG mice.

mRNA and protein expression analysis

from clipboard


Strain specific analysis of IFNGR2 gene expression in wild-type mice and B-hIFNGR2 mice by RT-PCR and western blotting. (A) mRNA expression. Mouse Ifngr2 mRNA was exclusively detectable in the small intestine of wild-type mice (+/+). Human IFNGR2 mRNA was exclusively detectable in homozygous B-hIFNGR2 mice (H/H). (B) Protein expression. Skeletal muscle was collected from wild-type C57BL/6 mice (+/+) and homozygous B-hIFNGR2 mice (H/H), and analyzed by western blotting with anti-IFNGR2 antibody which can recognize both human and mouse IFNGR2. The results show that IFNGR2 protein can be detected in homozygous B-hIFNGR2 mice.

IFNGR1 expression in different immune cells

from clipboard


IFNGR1 expression analysis in B-hIFNGR1/IFNG/hIFNGR2 mice. Splenocytes were collected from wild-type C57BL/6 mice and homozygous B-hIFNGR1/hIFNG/hIFNGR2 mice, and analyzed by flow cytometry with anti-IFNGR1 antibody. Human IFNGR1 was detectable in T cells, B cells and NK cells of B-hIFNGR1/hIFNG/hIFNGR2 mice. 


from clipboard


IFNGR1 expression analysis in B-hIFNGR1/hIFNG/hIFNGR2 mice. Splenocytes were collected from wild-type C57BL/6 mice and homozygous B-hIFNGR1/IFNG/hIFNGR2 mice, and analyzed by flow cytometry with anti-IFNGR1 antibody. Human IFNGR1 was detectable in granulocytes, macrophages and monocytes of B-hIFNGR1/hIFNG/hIFNGR2 mice. 

IFNγ induced phosphorylation of STAT1 in T, B and NK cells

from clipboard

Analysis of the IFNγ induced pSTAT1(Tyr701) in wild-type C57BL/6 mice and homozygous B-hIFNGR1/hIFNG/hIFNGR2 mice by flow cytometry. Splenocytes from wild-type mice and homozygous mice (female, 7-week-old) were treated with IFNγ for ex vivo, and then flow cytometry was performed to analyze the phosphorylation of STAT1. Mouse IFN-γ induced the expression of pSTAT1 in T and B cells of wild-type mice but not humanized mice. Human IFN-γ induced the expression of pSTAT1 in T and B cells of humanized mice but not wild-type mice. Among NK cells, IFN-γ not induced the STAT1 phosphorylation in both mice. 


IFNγ induced phosphorylation of STAT1 in T, B and NK cells


from clipboard


Analysis of the IFNγ induced pSTAT1(Tyr701) in wild-type C57BL/6 mice and homozygous B-hIFNGR1/hIFNG/hIFNGR2 mice by flow cytometry. Splenocytes from wild-type mice and homozygous mice (female, 7-week-old) were treated with IFNγ in doses shown in the panel for ex vivo, and then flow cytometry was performed to analyze the phosphorylation of STAT1. Mouse IFNγ induced the expression of pSTAT1 in T and B cells of wild-type mice but not humanized mice. Human IFNγ induced the expression of pSTAT1 in T and B cells of humanized mice but not wild-type mice. Among NK cells, IFNγ not induced the STAT1 phosphorylation in both mice. 

hIFNγ upregulates mPD-L1 in splenocytes from triple-KI mice, not WT mice

from clipboard


hIFNγ upregulated mPD-L1 in splenocytes from homozygous B-hIFNGR1/hIFNG/hIFNGR2 mice (Triple-KI). Splenocytes at 0.5x106/well (96-well plate) were treated with 100ng/mL hIFNγ for 24 hours at 37℃. Cells were collected and assessed for mPD-L1 expression by flow cytometry. As shown, hIFNγ induced the expression of mPD-L1 in triple-KI mice but not in wild-type mice. 
*The experiment is verified by the cooperation partner.

Activated splenocytes from triple-KI mice produce human IFNγ

from clipboard


Analysis of hIFNγ production in activated splenocytes from homozygous B-hIFNGR1/hIFNG/hIFNGR2 mice (Triple-KI). Cells were seeded in a 96-wells plate for 0.5X106 cells/well. The plate was precoated with 8μg/mL anti-mCD3 mAb at 4 ℃ for overnight. Then incubated the cells at 37℃ 5% CO2 for 5 days. Anti-CD28 at 1μg/mL and 100U hIL2 were added 16 hours after culture. Get the supernatant for ELISA analysis. hIFNγ was detection in triple-KI mice but not in wild-type mice. 
*The experiment is verified by the cooperation partner.